To amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings.

P.L. 113-235/H.R. 83, the Consolidated and Further Continuing Appropriations of FY 2015 Act. P.L. 113-164/H.J. Res. 124, the Continuing Appropriations Resolution, 2015. H.R. 4870/H.Report 113-473, the House Defense Appropriations for FY15. H.R. 4870/S. Report 113-211, the Senate Defense Appropriations for FY15. H.R. 2663/S. 1422, the Preventive Health Savings Act. *SEE NEXT PAGE FOR MORE DETAIL.P.L. 113-235/H.R. 83, the Consolidated and Further Continuing Appropriations of FY 2015 Act. Multiple clauses; provides funding through September 30, 2015, for the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). Our efforts were focused on increasing funding for both of these agencies, specifically the CDCs Division of Diabetes Translation (DDT) and National Diabetes Prevention Program and the NIHs National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). P.L. 113-164/H.J. Res. 124, the Continuing Appropriations Resolution, 2015. Multiple clauses; provides funding through December 11, 2014, for the CDC and the NIH. Our efforts were focused on increasing funding for both of these agencies, specifically the CDCs DDT and National Diabetes Prevention Program and the NIHs NIDDK. H.R. 4870/H.Report 113-473, the House Defense Appropriations for FY15. Attempt to include language including diabetes as a category for the Congressionally Directed Medical Research Program. H.R. 4870/S. Report 113-211, the Senate Defense Appropriations for FY15. Attempt to include language including diabetes as a category for the Congressionally Directed Medical Research Program. H.R. 2663/S. 1422, the Preventive Health Savings Act. Support entire bill; requires the Director of the Congressional Budget Office, upon a request by the chairman or ranking minority member of certain congressional committees, to determine if proposed legislation would result in reductions in budget outlays in budgetary outyears through the use of preventive health and preventive health services. H.R. 4800, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. Oppose language in bill that creates a waiver for the nutrition standards of the National School Lunch Program and the School Breakfast Program. S. 2389, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. Oppose attempts to add language that would roll back or weaken the nutrition standards for the National School Lunch Program and the School Breakfast Program. S. 2115, the America Cures Act. Support entire bill; provides funding for health research at the NIH, CDC, Department of Veterans Affairs and Department of Defense. S. 2658, the Accelerating Biomedical Research Act. Support entire bill; provides funding for health research at the NIH. Issues worked on not yet reflected in legislation: House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY15. Multiple clauses; provides funding for the DDT at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. Additionally, we are interested in the allocation of $20 million for the implementation of the National Diabetes Prevention Program. Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY15. Multiple clauses; provides funding for the DDT at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. Additionally, we are interested in the allocation of $20 million for the implementation of the National Diabetes Prevention Program. House Military Construction, Veteran Affairs and Other Related Agencies Appropriations for FY15. Attempt to include language supporting diabetes research in the Office of Research and Development. Senate Military Construction, Veteran Affairs and Other Related Agencies Appropriations for FY15. Attempt to include language supporting diabetes research in the Office of Research and Development.

Client expense: $128,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing. - Issues related to 21st Century Cures. - Issues related to Medicare beneficiary access. - Issues related to mobile medical applications and digital healthcare. - Issues related to FDA draft guidances on blood glucose meters. - HR 4895/ S 2902, "The Microbead Free Waters Act of 2014", regarding all provisions. - Issues related to the expanded use of unapproved drugs. - Issues related to combination products. - Issues related to the PROTECT Act (bill number pending), specifically medical mobile applications. - Issues related to Government Health Care Exclusion/ Debarment (bill number pending) - S 2977, "MEDTECH Act", regarding provisions related to medical mobile applications. - S 2917, "Adding Ebola to the FDA Priority Review Voucher Program Act", regarding all provisions.

Client expense: $1,400,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

Client expense: Not reported · Firm income: $27,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding HR 83 - Consolidated and Further Continuing Appropriations Act, 2015

Client expense: Not reported · Firm income: $27,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2663 and S. 1422, the Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program); P.L. 113-235, the Consolidated and Further Continuing Appropriations Act, 2015.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R.5780, Protecting Integrity of Medicare Act of 2014 (PIMA) H.R. 5860, the Small Business Healthcare Relief Act H.R. 83, CRomnibus - Consolidated & Further Continuing Appropriations Act, 2015 H.J. Res 124, Continuing Appropriations Resolution, 2015 H.R. 4015/S. 2000, SGR Repeal and Medicare Provider Payment Modernization Act of 2014 S.2966, Critical Care Assessment and Improvement Act of 2014 H.R. 4067, to provide for the extension of the enforcement instruction on supervision requirements for outpatient therapeutic services in critical access and small rural hospitals through 2014. S.2240, Medicare Choices Empowerment and Protection Act H.R. 4190, To amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services H.R. 2663/S. 1422 Preventive Health Savings Act H.R. 5644 Medicare CGM Access Act of 2014

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; FY14 Omnibus; H. Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program);H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013). H Con Res 96 the House FY 2015 Budget; H.J.Res 124 Continuing Appropriations Resolution FY15; P.L. 113-235 FY15 Consolidated and Continuing Appropriations

Client expense: $280,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to Round One recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.H.R. 2725 - FDA Safety Over Sequestration Act of 2013, and S. 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration H.R. 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like abdominal aortic aneurysm, hypertension screenings. H.R. 3077 The TELE-MED Act of 2013 provisions related to telemedicine and remote monitoring that increase access to health care and enhance patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of health information technology and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).

Client expense: $1,420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 452/H.R. 962, the Medicare Diabetes Prevention Act. H.R. 1915/S. 907, the Gestational Diabetes Act of 2013. H.R. 2178/S. 1033, the Fitness Integrated in Teaching (FIT) Kids Act. H.R. 2663/S. 1422, the Preventive Health Savings Act. H.R. 3322, the Eliminating Disparities in Diabetes Prevention, Access and Care Act. S. 1932, the Better Care, Lower Cost Act. H.R. 5294, the Health Equity and Accountability Act. S. 2210/H.R. 1783, the School Food Modernization Act.S. 452/H.R. 962, the Medicare Diabetes Prevention Act. Support entire bill; provides for Medicare coverage of National Diabetes Prevention Program. H.R. 1915/S. 907, the Gestational Diabetes Act of 2013. Support entire bill; provides funding for the establishment of a tracking and surveillance system at the CDC and provides grant funding for public health research on gestational diabetes. H.R. 2178/S. 1033, the Fitness Integrated in Teaching (FIT) Kids Act. Support entire bill; requires states to report on and reach physical education benchmarks; and requires training of physical education teachers and school administrators; physical education curriculum; and dedicated school space for physical education and physical activity. H.R. 2663/S. 1422, the Preventive Health Savings Act. Support entire bill; requires the Director of the Congressional Budget Office, upon a request by the chairman or ranking minority member of certain congressional committees, to determine if proposed legislation would result in reductions in budget outlays in budgetary outyears through the use of preventive health and preventive health services. H.R. 3322, the Eliminating Disparities in Diabetes Prevention, Access and Care Act. Support entire bill; expands resources at NIH, CDC, the Health Resources and Services Administration, and the Indian Health Service to promote research, treatment and education regarding diabetes in minority populations. S. 1932, the Better Care, Lower Cost Act. Support part of bill; establishes a Medicare Better Care Program to provide integrated care for Medicare beneficiaries with chronic conditions, and for other purposes. H.R. 5294, the Health Equity and Accountability Act. Support provisions addressing diabetes, including the Eliminating Disparities in Diabetes Prevention, Access and Care Act (sections 771-775) and the Gestational Diabetes Act (section 509). S. 2210/H.R. 1783, the School Food Modernization Act. Support entire bill; provides loans to schools to update kitchen equipment in order to prepare healthy foods for students. Issues worked on the Hill not yet reflected in legislation: Special Diabetes Program. The Special Diabetes Program consists of two mandatory funding streams Special Diabetes Program for type 1 and Special Diabetes Program for Indians. The funding is set to expire September 30, 2015 unless Congress acts to reauthorize the program. United States Preventive Services Task Force (USPSTF). Support any efforts to require the USPSTF to update its recommendation for diabetes screening, including gestational diabetes screening, based on new evidence. The Physician Payments Sunshine Act (also called the Open Payments Program) of the Affordable Care Act. Requires manufacturers of drugs, medical devices and biologicals that participate in U.S. federal health care programs to report certain payments and items of value given to physicians and teaching hospitals. The Association would like to see the Centers for Medicare and Medicaid Services make an Open Payments Program reporting exemption for indirect payments made to voluntary health agencies (VHAs) in cases when an applicable manufacturer grants full and independent discretion to VHAs in selecting recipients for funding.

Client expense: $123,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

P.L. 113-164/H.J. Res. 124, the Continuing Appropriations Resolution, 2015. H.R. 4870/H.Report 113-473, the House Defense Appropriations for FY15. H.R. 4870/S. Report 113-211, the Senate Defense Appropriations for FY15. H.R. 2663/S. 1422, the Preventive Health Savings Act. H.R. 4800, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. *SEE NEXT PAGE FOR MORE DETAIL.P.L. 113-164/H.J. Res. 124, the Continuing Appropriations Resolution, 2015. Multiple clauses; provides funding through December 11, 2014, for the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH). Our efforts were focused on increasing funding for both of these agencies, specifically the CDCs Division of Diabetes Translation (DDT) and National Diabetes Prevention Program and the NIHs National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). H.R. 4870/H.Report 113-473, the House Defense Appropriations for FY15. Attempt to include language including diabetes as a category for the Congressionally Directed Medical Research Program. H.R. 4870/S. Report 113-211, the Senate Defense Appropriations for FY15. Attempt to include language including diabetes as a category for the Congressionally Directed Medical Research Program. H.R. 2663/S. 1422, the Preventive Health Savings Act. Support entire bill; requires the Director of the Congressional Budget Office, upon a request by the chairman or ranking minority member of certain congressional committees, to determine if proposed legislation would result in reductions in budget outlays in budgetary outyears through the use of preventive health and preventive health services. H.R. 4800, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. Oppose language in bill that creates a waiver for the nutrition standards of the National School Lunch Program and the School Breakfast Program. S. 2389, the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act. Oppose attempts to add language that would roll back or weaken the nutrition standards for the National School Lunch Program and the School Breakfast Program. S. 2115, the America Cures Act. Support entire bill; provides funding for health research at the NIH, CDC, Department of Veterans Affairs and Department of Defense. S. 2658, the Accelerating Biomedical Research Act. Support entire bill; provides funding for health research at the NIH. Issues worked on not yet reflected in legislation: House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY15. Multiple clauses; provides funding for the DDT at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. Additionally, we are interested in the allocation of $20 million for the implementation of the National Diabetes Prevention Program. Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY15. Multiple clauses; provides funding for the DDT at the CDC as well as funding for the NIDDK at the NIH. Our efforts are focused on increased funding for both of these agencies. Additionally, we are interested in the allocation of $20 million for the implementation of the National Diabetes Prevention Program. House Military Construction, Veteran Affairs and Other Related Agencies Appropriations for FY15. Attempt to include language supporting diabetes research in the Office of Research and Development. Senate Military Construction, Veteran Affairs and Other Related Agencies Appropriations for FY15. Attempt to include language supporting diabetes research in the Office of Research and Development.

Client expense: $123,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Implementation of P.L. 111-148, The Patient Protection and Affordable Care Act; Title III- Improving the Quality and Efficiency of Health Care; S. 452/H.R. 962, The Medicare Diabetes Prevention Act of 2013; S. 351/H.R. 351, Protecting Seniors Access to Medicare Act of 2013; H.R. 241/S. 1184. Treat and Reduce Obesity Act- All provisions; H.R. 2663, To Amend the Congressional Budget Act Respecting Scoring of Prevention Health Savings- All Provisions; H.R. 4015/S.2000, The SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; P.L. 113-76 FY14 Omnibus; H Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY14 Labor/HHS/Education Appropriations (National Diabetes Prevention Program).H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing. - Issues related to 21st Century Cures. - Issues related to Medicare beneficiary access. - Issues related to mobile medical applications and digital healthcare. - Issues related to FDA draft guidances on blood glucose meters. - HR 4895/ S 2902, "The Microbead Free Waters Act of 2014", regarding all provisions. - Issues related to the expanded use of unapproved drugs. - Issues related to combination products. - Issues related to the PROTECT Act (bill number pending), specifically medical mobile applications. - Issues related to Government Health Care Exclusion/ Debarment (bill number pending)

Client expense: $1,350,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

Client expense: Not reported · Firm income: $27,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet, HJ Res 124 Continuing Appropriations Resolution, 2015 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

Client expense: Not reported · Firm income: $27,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2663 and S. 1422, the Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program).

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5380 The Medicare Telehealth Parity Act of 2014 S. 2552 The Medicare Advantage Participants Bill of Rights Act H.R. 4998, The Medicare Advantage Participants Bill of Rights Act S. 2553 The Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act) H.R. 4994, The Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act) S. 1932 The Better Care, Lower Cost Act H.R. 3890, The Better Care, Lower Cost Act S. 1422 The Preventive Health Savings Act H.R. 2663, The Preventive Health Savings Act H.R. 5279, The Sugar-Sweetened Beverages Tax (SWEET) Act S.2574, The Healthy Families Act of 2014 H.R. 1024, The Medication Therapy Management Empowerment Act S. 2240, The Medicare Choices Empowerment and Protection Act S. 2000 SGR Repeal and Medicare Provider Payment Modernization Act of 2014 H.R. 4015 SGR Repeal and Medicare Provider Payment Modernization Act of 2014 HR. 4418, the Expanding the Availability of Medicare Data Act H.R. 2843 Medicare Data Access for Transparency and Accountability Act S. 1180 Medicare Data Access for Transparency and Accountability Act H.R. 3077, TELEmedicine for MEDicare (TELE-MED) Act H.R. 4190, a bill that would will allow Medicare reimbursement for Part B services performed by a pharmacist in underserved communities, among other activities. H.R.1070, Removing Barriers to Colorectal Cancer Screening Act of 2013 H.R. 1074 National Diabetes Clinical Care Commission Bill S. 539, National Diabetes Clinical Care Commission Bill

Client expense: $160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; FY14 Omnibus; H. Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program);H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013). H Con Res 96 the House FY 2015 Budget; H.J.Res 124 Continuing Appropriations Resolution FY15

Client expense: $910,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

S. 907/H.R. 1915 Gestational Diabetes (GEDI) Act S. 539 National Diabetes Clinical Care Commission ActH.R. 1074 National Diabetes Clinical Care Commission Act H.R. 2663/S. 1422 Preventative Health Savings Act Affordable Care Act - Preventative Services H.R. 6543 Older Americans Act

Client expense: $20,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research

Client expense: $1,580,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program).

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research Issues related to the discovery, development and delivery of promising new treatments to patients (21st Century Cures).

Client expense: $1,360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 452/H.R. 962, the Medicare Diabetes Prevention Act., H.R. 1915/S. 907, the Gestational Diabetes Act of 2013, H.R. 2178/S. 1033, the Fitness Integrated in Teaching (FIT) Kids Act, H.R. 2343, the Healthy Food Financing Initiative, H.R. 2663/S. 1422, the Preventive Health Savings Act, H.R. 3322, Eliminating Disparities in Diabetes Prevention, H.R. 3591, Minority Diabetes Initiative Act, S. 1932, Better Care, Lower Cost Act. ( See next page for details).S. 452/H.R. 962, the Medicare Diabetes Prevention Act. Support entire bill providing for Medicare Coverage of National Diabetes Prevention Program. H.R. 1915/S. 907, the Gestational Diabetes Act of 2013. Support entire bill; provides funding for the establishment of a tracking and surveillance system at the Centers for Disease Control and Prevention and provides grant funding for public health research on gestational diabetes. H.R. 2178/S. 1033, the Fitness Integrated in Teaching (FIT) Kids Act. Support entire bill; requires states to report on and reach physical education benchmarks; and requires training of physical education teachers and school administrators; physical education curriculum; and dedicated school space for physical education and physical activity. H.R. 2343, the Healthy Food Financing Initiative. Support entire bill; to provide financing to expand or improve supermarkets, grocery stores and other retail food options in underserved areas in order to make healthier food options available. H.R. 2663/S. 1422, the Preventive Health Savings Act. Support entire bill; to require the Director of the Congressional Budget Office (CBO), upon a request by the chairman or ranking minority member of certain congressional committees, to determine if proposed legislation would result in reductions in budget outlays in budgetary outyears through the use of preventive health and preventive health services. H.R. 3322, Eliminating Disparities in Diabetes Prevention, Access and Care Act. Support entire bill; expands resources at NIH, CDC, HRSA, and IHS to promote research, treatment, and education regarding diabetes in minority populations. H.R. 3591, Minority Diabetes Initiative Act. Support entire bill; provides grants for improved diabetes care for minority populations. S. 1932, Better Care, Lower Cost Act. Support part of bill; establishes a Medicare Better Care Program to provide integrated care for Medicare beneficiaries with chronic conditions, and for other purposes. Issues worked on the Hill not yet reflected in legislation: United States Preventive Services Task Forcesupport any efforts to require the USPSTF to update its recommendation for diabetes screening including gestational diabetes screening based on new evidence.

Client expense: $138,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 2663/S. 1422, the Preventive Health Savings Act., H.R. 4800, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act., S. 2115, the America Cures Act., H.R. 2389, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act. ( See next page for details)H.R. 2663/S. 1422, the Preventive Health Savings Act. Support entire bill; to require the Director of the Congressional Budget Office (CBO), upon a request by the chairman or ranking minority member of certain congressional committees, to determine if proposed legislation would result in reductions in budget outlays in budgetary outyears through the use of preventive health and preventive health services. H.R. 4800, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act. Oppose language in bill that creates a waiver for the nutrition standards of the National School Lunch Program and the School Breakfast Program. S. 2115, the America Cures Act. Support entire bill; provides funding for health research at the NIH, CDC, Department of Veterans Affairs and Department of Defense. H.R. 2389, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act. Oppose attempts to add language that would roll back or weaken the nutrition standards for the National School Lunch Program and the School Breakfast Program. Issues worked on the Hill not yet reflected in legislation: House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY15 Multiple clauses; Provides funding for the Division of Diabetes Translation (DDT) at the Centers for Disease Control and Prevention (CDC) as well as funding for research at the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). Our efforts are focused on increased funding for both of these agencies, on behalf of those who will benefit from the research and education/information programs that they provide. Additionally, we are interested in the allocation of $20 million for the implementation of the National Diabetes Prevention Program (NDPP). Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY15 Multiple clauses; Provides funding for the Division of Diabetes Translation (DDT) at the Centers for Disease Control and Prevention (CDC) as well as funding for research at the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). Our efforts are focused on increased funding for both of these agencies, on behalf of those who will benefit from the research and education/information programs that they provide. Additionally, we are interested in the allocation of $20 million for the implementation of the National Diabetes Prevention Program (NDPP). House Defense Appropriations for FY15; attempt to include language including diabetes as a category for the Congressionally Directed Medical Research Program. Senate Defense Appropriations for FY15; attempt to include language including diabetes as a category for the Congressionally Directed Medical Research Program. House Military Construction, Veteran Affairs, and Other Related Agencies Appropriations for FY15; attempt to include language supporting diabetes research on the Office of Research and Development. Senate Military Construction, Veteran Affairs, and Other Related Agencies Appropriations for FY15; attempt to include language supporting diabetes research on the Office of Research and Development. Health Equity and Accountability Actsupport provisions addressing diabetes, including the Eliminating Disparities in Diabetes Prevention, Access and Care Act and the Gestational Diabetes Act.

Client expense: $138,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; P.L. 113-76 FY14 Omnibus; H Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY14 Labor/HHS/Education Appropriations (National Diabetes Prevention Program).H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

Implementation of P.L. 111-148, The Patient Protection and Affordable Care Act; Title III - Improving the Quality and Efficiency of Health Care; S. 452/H.R. 962, The Medicare Diabetes Prevention Act of 2013; S. 351/H.R. 351, Protecting Senior's Access to Medicare Act of 2013; H.R. 2415/S. 1184. Treat and Reduce Obesity Act- All Provisions; H.R. 2663, To Amend the Congressional Budget Act Respecting Scoring of Prevention Health Savings - All Provisions; H.R. 4015/S.2000, The SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - HR 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014", regarding all provisions. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing. - Issues related to 21st Century Cures. - Issues related to Medicare beneficiary access. - Issues related to mobile medical applications and digital healthcare. - Issues related to FDA draft guidances on blood glucose meters. - HR 4895, "The Microbead Free Waters Act of 2014", regarding all provisions. - Issues related to the expanded use of unapproved drugs.

Client expense: $1,060,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yet In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

Client expense: Not reported · Firm income: $27,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 H Con Res 96 Establishing the budget for the United States Government for fiscal year 2015 and setting forth appropriate budgetary levels for fiscal years 2016 through 2024/no Senate companion yetIn all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

Client expense: Not reported · Firm income: $27,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; FY14 Omnibus; H. Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program);H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013). H Con Res 96 the House FY 2015 Budget

Client expense: $440,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

S. 2176, the Commonsense Reporting Act of 2014 H.R. 4414, the Expatriate Health Coverage Clarification Act of 2014 H.R. 3474, the Hire More Heroes Act of 2014 H.R. 1814, the EACH ActH.R. 3979, the Emergency Unemployment Compensation Extension Act of 2014 S. 1729, Expanded Consumer Choice Act S. 1333, Increased Competition for Consumers Act S. 2069, Small Business Tax Credit Accessibility Act S. 2173, CHOICE Act H.R. 2575, the Save American Workers of 2014 H.R. 4118, the SIMPLE Fairness Act S. 2461, the CHIP Extension Act of 2014 S. 2446, Truth in Obamacare Accounting Act H.R.4865 / S.2434, Family Coverage Act H.R. 4406, Taxpayer Bailout Protection Act H.R. 4438, American Research and Competitiveness Act of 2014 H.R. 4106, Saving Lives, Saving Costs Act S. 2229, the Expanding Primary Care Access and Workforce Act H.R. 2663 / S. 1422, the Preventive Health Savings Act H.R. 4574, Strengthening Mental Health in Our Communities Act of 2014 H.R.3717, Helping Families in Mental Health Crisis Act of 2013 H.R.4775 / S.2462, Safeguarding Classrooms Hurt by ObamaCare's Obligatory Levies H.R. 3303, Sensible Oversight for Technology Which Advances Regulatory Efficiency (SOFTWARE) Act S. 2007, Preventing Regulatory Overreach To Enhance Care Technology (PROTECT) Act of 2014 H.R. 1074/S. 539, the National Diabetes Clinical Care Commission Act H.R.962/S. 452, the Medicare Diabetes Prevention Act H.R. 1024/ S. 557 the Medication Therapy Management Empowerment H.R. 4444, the Long-Term Studies of Comprehensive Outcomes and Returns for the Economy (SCORE) Act

Client expense: $160,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S. 2467 National Defense Authorization Act Army Medical Army Medical Specialty Corps (AMSC) S. 907/ H.R. 1915 Gestational Diabetes (GEDI) Act S. 539 National Diabetes Clinical Care Commission ActH.R. 1074 National Diabetes Clinical Care Commission Act H.R. 2663/ S. 1422 Preventative Health Savings Act S. 959 Pharmaceutical Compounding Quality and Accountability Act Affordable Care Act - Preventative Services H.R. 6543 Older Americans Act

Client expense: $20,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of P.L. 111-148, The Patient Protection and Affordable Care Act; Title III - Improving the Quality and Efficiency of Health Care; S. 452/H.R. 962, The Medicare Diabetes Prevention Act of 2013; S. 351/H.R. 351, Protecting Senior's Access to Medicare Act of 2013; H.R. 2415/S. 1184. Treat and Reduce Obesity Act- All Provisions; H.R. 2663, To Amend the Congressional Budget Act Respecting Scoring of Prevention Health Savings - All Provisions; H.R. 4015/S.2000, The SGR Repeal and Medicare Provider Payment Modernization Act of 2014, all provisions.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 452/H.R. 962, the Medicare Diabetes Prevention Act. H.R. 1915/S. 907, the Gestational Diabetes Act of 2013. H.R. 1249, the Common Sense Nutrition Disclosure Act. H.R. 2178/S. 1033, the Fitness Integrated in Teaching (FIT) Kids Act. H.R. 1783, the School Food Modernization Act. H.R. 2343, the Healthy Food Financing Initiative. H.R. 1947, the Federal Agriculture Reform and Risk Management Act/S.954. H.R. 2663/S. 1422, the Preventive Health Savings Act. H.R. 3322, H.R. 3591, S. 1932. See next page.S. 452/H.R. 962, the Medicare Diabetes Prevention Act. Support entire bill providing for Medicare Coverage of National Diabetes Prevention Program. H.R. 1915/S. 907, the Gestational Diabetes Act of 2013. Support entire bill; provides funding for the establishment of a tracking and surveillance system at the Centers for Disease Control and Prevention and provides grant funding for public health research on gestational diabetes. H.R. 1249, the Common Sense Nutrition Disclosure Act. Oppose entire bill; makes exemptions to nutrition labeling in chain restaurants as required by the Patient Protection and Affordable Care Act. H.R. 2178/S. 1033, the Fitness Integrated in Teaching (FIT) Kids Act. Support entire bill; requires states to report on and reach physical education benchmarks; and requires training of physical education teachers and school administrators; physical education curriculum; and dedicated school space for physical education and physical activity. H.R. 1783, the School Food Modernization Act. Support entire bill, provides loan guarantees and grants for schools to improve their facilities in order to prepare and serve healthier meals. H.R. 2343, the Healthy Food Financing Initiative. Support entire bill; to provide financing to expand or improve supermarkets, grocery stores and other retail food options in underserved areas in order to make healthier food options available. H.R. 1947, the Federal Agriculture Reform and Risk Management Act/S. 954, the Agriculture Reform, Food and Jobs Act (the Farm Bill). Support Healthy Food Financing Provision, to provide financing to expand or improve supermarkets, grocery stores and other retail food options in underserved areas in order to make healthier food options available. H.R. 2663/S. 1422, the Preventive Health Savings Act. Support entire bill; to require the Director of the Congressional Budget Office (CBO), upon a request by the chairman or ranking minority member of certain congressional committees, to determine if proposed legislation would result in reductions in budget outlays in budgetary outyears through the use of preventive health and preventive health services H.R. 3322, Eliminating Disparities in Diabetes Prevention, Access and Care Act. Support entire bill; expands resources at NIH, CDC, HRSA, and IHS to promote research, treatment, and education regarding diabetes in minority populations. H.R. 3591, Minority Diabetes Initiative Act. Support entire bill; provides grants for improved diabetes care for minority populations. S. 1932, Better Care, Lower Cost Act. Support part of bill; establishes a Medicare Better Care Program to provide integrated care for Medicare beneficiaries with chronic conditions, and for other purposes. Issues worked on the Hill not yet reflected in legislation: United States Preventive Services Task Forcesupport any efforts to require the USPSTF to update its recommendation for diabetes screening including gestational diabetes screening based on new evidence. Seek support for nomination of Dr. Elbert Huang to serve on the USPSTF. Support Surgeon General nominee Vivek Murthy. Special Diabetes Program educate Congress on the good work the program is doing in research and prevention and the need to reauthorize this program; Also support provision in the Senate Finance mark of the Sustainable Growth Rate which reauthorized the program for 5 years. Medicare Sustainable Growth Ratesupport efforts to include Medicare Diabetes Prevention Act and the Special Diabetes Program in moving legislation.

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 3547 (P.L. 113-76), the Omnibus Appropriations Act, 2014. HJ. Res 106 (P.L. 113-73), the Continuing Appropriations Act, 2014. H.R. 2663/S. 1422, the Preventive Health Savings Act. (See next Page for specific issues descriptions)H.R. 3547 (P.L. 113-76), the Omnibus Appropriations Act, 2014. Multiple clauses; provides funding through September 30, 2014, for the Centers for Disease Control and Prevention (CDC) as well as funding for research at the National Institutes of Health (NIH). Our efforts were focused on increased funding for both of these agencies, specifically at the CDCs Division of Diabetes Translation and the National Diabetes Prevention Program at the agency, and the NIHs National Institute of Diabetes and Digestive and Kidney Diseases on behalf of those who will benefit from the diabetes research and education/information programs that they provide. HJ. Res 106 (P.L. 113-73), the Continuing Appropriations Act, 2014. Multiple clauses; provides funding through January 18, 2014, for the Centers for Disease Control and Prevention (CDC) as well as funding for research at the National Institutes of Health (NIH). Our efforts were focused on increased funding for both of these agencies, specifically at the CDCs Division of Diabetes Translation and the National Diabetes Prevention Program at the agency, and the NIHs National Institute of Diabetes and Digestive and Kidney Diseases on behalf of those who will benefit from the diabetes research and education/information programs that they provide. H.R. 2663/S. 1422, the Preventive Health Savings Act. Support entire bill; to require the Director of the Congressional Budget Office (CBO), upon a request by the chairman or ranking minority member of certain congressional committees, to determine if proposed legislation would result in reductions in budget outlays in budgetary outyears through the use of preventive health and preventive health services. Issues worked on the Hill not yet reflected in legislation: House Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY15 Multiple clauses; Provides funding for the Division of Diabetes Translation (DDT) at the Centers for Disease Control and Prevention (CDC) as well as funding for research at the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). Our efforts are focused on increased funding for both of these agencies, on behalf of those who will benefit from the research and education/information programs that they provide. Additionally, we are interested in the allocation of $20 million for the implementation of the National Diabetes Prevention Program (NDPP). Senate Departments of Labor, Health and Human Services, and Education and Related Agencies (LHHS) Appropriations Act for FY15 Multiple clauses; Provides funding for the Division of Diabetes Translation (DDT) at the Centers for Disease Control and Prevention (CDC) as well as funding for research at the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH). Our efforts are focused on increased funding for both of these agencies, on behalf of those who will benefit from the research and education/information programs that they provide. Additionally, we are interested in the allocation of $20 million for the implementation of the National Diabetes Prevention Program (NDPP). House Defense Appropriations for FY15; attempt to include language including diabetes as a category for the Congressionally Directed Medical Research Program. Senate Defense Appropriations for FY15; attempt to include language including diabetes as a category for the Congressionally Directed Medical Research Program. House Military Construction, Veteran Affairs, and Other Related Agencies Appropriations for FY15; attempt to include language supporting diabetes research on the Office of Research and Development. Senate Military Construction, Veteran Affairs, and Other Related Agencies Appropriations for FY15; attempt to include language supporting diabetes research on the Office of Research and Development. Opposing cost-shifting, cuts to or the block granting of federal entitlement programs, specifically Medicaid and Medicare. In addition, opposing structural changes to the Medicare program including the combining of Parts A and B deductibles and imposing new co-pays for home health services.

Client expense: $200,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 Medicare Diabetes Prevention Act of 2013; HR 1257 - Prevent Diabetes in Medicare Act of 2013; HR 1247/S 945 - Access to Quality Diabetes Education Act of 2013; HR 2663/ S 1422 Scoring of Preventive Health Savings; and S 1284 - Department of Labor, Health and Human Services and Education and Related Agencies Appropriations Act of 2014, specifically NDPP funding

Client expense: Not reported · Firm income: $27,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

FY 2014 Omnibus HR 3547 FY 2014 Continuing Resolution H J Res 106 PL 113-73 FY 2014 Continuing Resolution H J Res 59 PL 113-67 HR 4302 SGR Patch Protecting Access to Medicare Act of 2014 - Public Law No: 113-93 In all of the above the specific issues included potential Medicare offsets that might be applied to prescription drugs HR 962/S 452 - Medicare Diabetes Prevention Act of 2013 HR 1257 Prevent Diabetes Medicare Act of 2013 HR 1274/S 945 Access to Quality Diabetes Education Act of 2013; HR 1588/ S 740 -- Medicare Drug Savings Act of 2013 HR 2415/ S 1184 - Treat and Reduce Obesity Act of 2013; HR 2663/S 1422 - Scoring of Preventive Health Savings Medicare diabetes screening and self management

Client expense: Not reported · Firm income: $27,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; FY14 Senate Budget Resolution; H Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY14 Labor/HHS/Education Appropriations (National Diabetes Prevention Program).H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013). FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program)

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE

- Issues related to ensuring quality of supply chain for FDA regulated products. - Issues related to Accountable Care Organizations. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to Physician Payment Sunshine provisions. - Issues related to regulation and reimbursement of diagnostics.- Issues related to health care reform, regarding Medicare wellness benefit. - Issues related to maintaining the biosimilars statute without changes. - HR 1074, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 539, "National Diabetes Clinical Care Commission Act", regarding all provisions. - S 452, "Medicare Diabetes Prevention Act of 2013", regarding all provisions. - Issues related to personalized medicine incentives and regulation. - Issues related to Moddern Cures initiative. - Issues related to modernizing laboratory test standards. - Issues related to diagnostic payments. - PL 111-148, "Patient Protection and Affordable Care Act", issues related to vision care coverage. - PL 112-144, "Food and Drug Administration Safety and Innovation Act", regarding Medical Device User Fee Act provisions. - Issues related to the repeal and/or reform of Independent Payment Advisory Boards. - Issues related to hepatitis C testing and treatment guidelines. - PL 101-381, "Ryan White Comprehensive AIDS Resources Emergency (CARE) Act" and issues related to state ADAP funding. - Issues related to drug resistant tuberculosis. - Issues related to legislation that would establish drug importation. - Issues related to legislation that would establish a rebate in the Medicare Part D program. - Issues related to legislation that would modify the Medicare Part B drug reimbursement program. - Issues related to medical device reprocessing. - HR 2375, "Competitive Bidding for DME Delay", regarding all provisions. - Issues related to health care pricing transparency. - HR 3303, "Mobile Medical Application", regarding all provisions. - HR 2085, "Diagnostic Payment Reform", regarding all provisions. - Issues related to health care associated inflation policy. - HR 2663/ S 1422, "Preventative Health Savings Act", regarding all provisions. - HR 3204, "Drug Quality and Security Act", regarding all provisions. - Issues related to neglected tropical diseases. - Issues related to transferable market exclusivity. - HR 4015, "SGR Repeal and Medicare Provider Payment Modernization Act of 2014", regarding all provisions. - Issues related to health care associated infections. - S 959, "Pharmaceutical Quality Security and Accountability Act", regarding all provisions. - Issues related to FDA regulation of custom medical devices. - Issues related to Tricare coverage of Total Disc Arthroplasty. - Issues related to VA requirements for vendor access and credentialing.

Client expense: $2,110,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

National Diabetes Prevention Program; H.R. 2663 and S. 1422, The Preventative Health Savings Act of 2013.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2375 -Transparency and Accountability in Medicare Bidding Act of 2013 - provisions related to round one recompete and implications for diabetes products. HR 2810 - The Medicare Patient Access and Quality Improvement Act of 2013 - issues related to reform of the physician fee schedule and the SGR formula.HR 2725 - FDA Safety Over Sequestration Act of 2013, and S 1413 FDA User Fee Protection Act - provisions related to protecting industry paid user fees from sequestration HR 2663 & S. 1422 - The Preventative Health Savings Act - provisions that will permit leaders in Congress to request that CBO estimate the long-term health savings that are possible from preventative health initiatives like Abdominal Aortic Aneurysm, Hypertension screenings. H.R. 3077 The Tele-med Act of 0213 provisions related to telemedicine and remote monitoring that increase access to health care and enhane patient outcomes H.R. 3303 Software Act of 2013 - provisions related to FDA regulation of HIT and mobile medical applications S. 1932 - Better Care, Lower Cost Act - provisions related to management of chronic disease H.R. - 3890 - Better Care, Lower Cost Act - provisions related to management of chronic disease Issues related to neuroscience research

Client expense: $1,480,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE